Target intelligence / Profile preview

Intracellular invasion

Molecular classification
Biological Process, Host-pathogen interaction
01

Overview

Intracellular invasion is a complex biological process through which pathogenic organisms, including viruses, bacteria, and parasites, gain entry into host cells to facilitate their survival and replication (10). This multi-step phenomenon typically begins with the specific attachment of pathogen surface ligands to host cell receptors, followed by the activation of cellular signaling pathways that trigger internalization via mechanisms like receptor-mediated endocytosis, macropinocytosis, or direct membrane fusion (3, 7). Once inside, pathogens may reside within membrane-bound vacuoles or escape into the cytoplasm to evade host immune defenses such as antibodies and complement proteins (1, 6). Because it encompasses a wide array of distinct molecular interactions involving various host and pathogen factors, intracellular invasion is characterized as a biological phenomenon rather than a single molecular target. Therapeutic strategies targeting this process, often termed entry inhibitors or host-directed therapies, aim to prevent the initiation of the infection cycle by blocking these early interactions or enhancing the host's ability to clear invaded pathogens (2, 9).

Other names
Cell entryPathogen internalizationHost cell invasionPathogen uptakeInvasion process
02

Mechanism of action

Inhibition of pathogen-host receptor binding, blocking of membrane fusion, disruption of endocytic pathways, or induction of host-directed autophagy to clear internalized pathogens.

03

Biological functions

Pathogen entryEndocytosisMembrane fusionPhagocytosisImmune evasionIntracellular replication
04

Disease associations

InfectionViral infectionBacterial infectionParasitic infectionSepsis
05

Safety considerations

Interference with normal physiological endocytosis/exocytosisPotential for host cell toxicity with non-specific inhibitorsRapid development of pathogen resistance via surface protein mutationsDifficulty in achieving effective drug concentrations within specific intracellular niches
06

Interacting drugs

Maraviroc

5 more in the full profile.

07

Biomarkers

Viral loadBacterial colony-forming units (CFU)Intracellular pathogen countHost receptor expression levels (e.g., CCR5, ACE2)

Beyond the preview

Go deeper on Intracellular invasion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intracellular invasion.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call